NanoVibronix, Inc. (NAOV)
| Market Cap | 23.13M |
| Revenue (ttm) | 620,000 |
| Net Income (ttm) | -4.51M |
| Shares Out | 9.34M |
| EPS (ttm) | -0.61 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $1.38 |
| Previous Close | $1.36 |
| Change ($) | 0.02 |
| Change (%) | 1.10% |
| Day's Open | 1.55 |
| Day's Range | 1.28 - 1.77 |
| Day's Volume | 53,864,008 |
| 52-Week Range | 0.56 - 2.90 |
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therap...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
A NanoVibronix (NAOV) alert for investors is in order Wednesday as the medical device company's stock is skyrocketing higher. The post NanoVibronix Alert: Why NAOV Stock Is Skyrocketing 133% T...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ul...
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave...
ELMSFORD, N.Y., Sept. 29, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SA...
ELMSFORD, N.Y., Sept. 22, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface...
ELMSFORD, N.Y., Sept. 22, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface...
NanoVibronix (NAOV) news for Tuesday includes approval from the U.S. Food and Drug Administration sending NAOV stock soaring.
ELMSFORD, N.Y., Aug. 27, 2020 /PRNewswire/ -- NanoVibronix, Inc.
ELMSFORD, N.Y., Aug. 24, 2020 /PRNewswire/ -- NanoVibronix, Inc.
ELMSFORD, N.Y., Aug. 24, 2020 /PRNewswire/ -- NanoVibronix, Inc.
NanoVibronix (NASDAQ: NAOV) shares are trading higher on Wednesday. The company announced it has received reimbursement approval from the U.S.
Enables Providers to Prescribe PainShield to Help Individuals Manage Pain at Home, Avoiding Unnecessary Doctor Visits and Hospitalization During COVID-Related Stay-At-Home Proclamations Enable...
Appealing to potential Regulatory agencies to increase use to reduce burden on the healthcare system Appealing to potential Regulatory agencies to increase use to reduce burden on the healthca...
Nanocap medical device company NanoVibronix announced it's developing cannabidiol patches and cream utilizing a proprietary and nanoparticle-based infusion process.
About NAOV
NanoVibronix, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint c... [Read more...]
| Industry Medical Devices | Founded 2003 |
| CEO Brian Murphy | Employees 10 |
| Stock Exchange NASDAQ | Ticker Symbol NAOV |
Financial Performance
In 2019, NanoVibronix's revenue was $530,000, an increase of 66.67% compared to the previous year's $318,000. Losses were -$5.79 million, 39.5% more than in 2018.